Equities

Vaso Corp

VASO:QXR

Vaso Corp

Actions
  • Price (USD)0.2624
  • Today's Change-0.003 / -0.98%
  • Shares traded44.82k
  • 1 Year change+11.45%
  • Beta2.2230
Data delayed at least 15 minutes, as of May 03 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vaso Corporation is principally engaged in operating the healthcare equipment and information technology industries. The Company's segments include IT, Professional sales service, and Equipment. The IT segment operates through a wholly owned subsidiary, VasoTechnology, Inc., which primarily focuses on healthcare information technology (IT) and managed network technology services. Its Professional sales service segment operates through a wholly owned subsidiary, Vaso Diagnostics, Inc. doing business as VasoHealthcare, primarily focuses on the sale of healthcare capital equipment for GE HealthCare (GEHC) into the health provider middle market. Its Equipment segment primarily focuses on the design, manufacture, sale and service of proprietary medical devices and software, operating through the Company's subsidiary, VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.

  • Revenue in USD (TTM)81.02m
  • Net income in USD4.81m
  • Incorporated1987
  • Employees300.00
  • Location
    Vaso Corp137 Commercial St Ste 200PLAINVIEW 11803-2410United StatesUSA
  • Phone+1 (516) 997-4600
  • Fax+1 (302) 655-5049
  • Websitehttps://vasocorporation.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Co-Diagnostics Inc6.81m-35.33m37.51m155.00--0.4361--5.51-1.20-1.200.23212.750.06241.203.6343,948.71-32.365.77-33.856.1538.5782.24-518.6810.9410.52--0.000.00-80.09179.54-148.15--101.27--
iCAD Inc17.32m-7.01m39.54m67.00--1.18--2.28-0.2742-0.19250.67471.270.37190.80342.16258,477.60-15.06-23.94-19.23-34.1485.3776.96-40.48-45.024.26--0.00---12.54-7.5329.32--23.88--
Nutriband Inc2.09m-5.28m40.04m13.00--5.01--19.17-0.6738-0.67380.26640.72910.21767.1216.70---55.06-60.48-59.75-74.6638.8027.55-253.02-388.142.54-142.450.2792--46.23--29.65------
United Health Products Inc0.00-2.62m42.58m6.00---------0.011-0.0110.00-0.0070.000.00--0.00-826.01-6,446.86------53.19---132,561.200.0606-20.88-----100.00---55.45------
Cytosorbents Corp36.35m-28.51m44.50m186.00--1.91--1.22-0.6375-0.63750.81320.42910.62413.916.20195,426.80-48.94-36.00-61.82-43.5261.6068.15-78.43-62.711.51--0.1781--4.7910.0613.12---9.24--
DarioHealth Corp20.35m-63.51m44.75m276.00--0.7109--2.20-2.24-2.240.71742.140.18882.214.2573,739.13-55.13-73.26-64.69-87.5929.4029.54-292.00-293.543.38--0.3293---26.4122.450.5091--52.42--
IRIDEX Corp51.87m-9.57m46.31m111.00--4.86--0.8929-0.5934-0.59343.220.58591.352.938.01467,288.30-24.95-19.54-37.31-27.4642.0442.67-18.45-15.451.35--0.00---8.964.02-26.81---24.35--
Vaso Corp81.02m4.81m46.46m300.008.831.738.000.57340.030.030.46260.15311.1020.686.03270,080.006.527.6011.1916.6262.4458.395.935.821.45--0.0043--2.181.84-57.46---22.33--
InspireMD Inc6.21m-19.92m47.04m65.00--1.11--7.58-1.08-1.080.25651.810.17172.364.3795,461.54-55.10-60.59-65.08-72.9729.1220.46-320.97-334.786.99--0.00--20.0011.50-7.71--41.57--
Lucid Diagnostics Inc2.43m-52.67m47.30m70.00------19.48-1.26-1.260.0582-0.05460.0812--78.3234,685.71-176.20---479.39---146.21---2,169.11--0.7418--1.11--544.03--6.24------
Apyx Medical Corp52.35m-18.71m49.19m252.00--1.84--0.9397-0.5403-0.54031.510.77070.79911.714.25207,734.10-28.78-25.24-35.57-29.9764.4966.11-36.01-46.004.74-12.810.5526--17.6125.8219.28--7.99--
Cutera Inc212.37m-150.83m51.30m540.00------0.2416-7.57-7.5710.68-8.010.48482.424.78---34.43-20.98-43.99-29.2128.4549.47-71.02-26.072.44-46.541.62---15.865.47-83.18--86.13--
Milestone Scientific Inc9.83m-6.93m53.32m17.00--6.59--5.43-0.0949-0.09490.13460.10560.78390.851419.53578,085.30-55.68-55.48-73.81-74.7269.1363.97-71.04-88.942.21--0.0013--11.600.423320.41---7.99--
Icecure Medical Ltd3.23m-14.65m53.96m71.00--4.44--16.71-0.3211-0.32110.07080.2660.13860.751835.6845,478.88-62.89-54.89-76.33-68.6640.2649.87-453.76-313.193.08--0.00--4.6723.5013.70--48.10--
Beyond Air Inc689.00k-66.70m56.00m98.00--2.08--81.27-2.13-2.130.02190.58670.0111.441.247,030.61-112.64-70.88-148.49-88.69-115.24---10,288.68-1,530.313.26--0.382-------29.27------
Data as of May 03 2024. Currency figures normalised to Vaso Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.